463 related articles for article (PubMed ID: 32179176)
1. Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD.
Fallini C; Khalil B; Smith CL; Rossoll W
Neurobiol Dis; 2020 Jul; 140():104835. PubMed ID: 32179176
[TBL] [Abstract][Full Text] [Related]
2. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
Chou CC; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM; Seyfried NT; Powers MA; Kukar T; Hales CM; Gearing M; Cairns NJ; Boylan KB; Dickson DW; Rademakers R; Zhang YJ; Petrucelli L; Sattler R; Zarnescu DC; Glass JD; Rossoll W
Nat Neurosci; 2018 Feb; 21(2):228-239. PubMed ID: 29311743
[TBL] [Abstract][Full Text] [Related]
3. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport.
Zhang K; Daigle JG; Cunningham KM; Coyne AN; Ruan K; Grima JC; Bowen KE; Wadhwa H; Yang P; Rigo F; Taylor JP; Gitler AD; Rothstein JD; Lloyd TE
Cell; 2018 May; 173(4):958-971.e17. PubMed ID: 29628143
[TBL] [Abstract][Full Text] [Related]
4. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.
Zhang K; Grima JC; Rothstein JD; Lloyd TE
Nucleus; 2016 Apr; 7(2):132-7. PubMed ID: 27116041
[TBL] [Abstract][Full Text] [Related]
5. G
Coyne AN; Zaepfel BL; Hayes L; Fitchman B; Salzberg Y; Luo EC; Bowen K; Trost H; Aigner S; Rigo F; Yeo GW; Harel A; Svendsen CN; Sareen D; Rothstein JD
Neuron; 2020 Sep; 107(6):1124-1140.e11. PubMed ID: 32673563
[TBL] [Abstract][Full Text] [Related]
6. LSM12-EPAC1 defines a neuroprotective pathway that sustains the nucleocytoplasmic RAN gradient.
Lee J; Park J; Kim JH; Lee G; Park TE; Yoon KJ; Kim YK; Lim C
PLoS Biol; 2020 Dec; 18(12):e3001002. PubMed ID: 33362237
[TBL] [Abstract][Full Text] [Related]
7. Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD.
Coyne AN; Rothstein JD
Acta Neuropathol Commun; 2021 Mar; 9(1):45. PubMed ID: 33741069
[TBL] [Abstract][Full Text] [Related]
8. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang K; Donnelly CJ; Haeusler AR; Grima JC; Machamer JB; Steinwald P; Daley EL; Miller SJ; Cunningham KM; Vidensky S; Gupta S; Thomas MA; Hong I; Chiu SL; Huganir RL; Ostrow LW; Matunis MJ; Wang J; Sattler R; Lloyd TE; Rothstein JD
Nature; 2015 Sep; 525(7567):56-61. PubMed ID: 26308891
[TBL] [Abstract][Full Text] [Related]
9. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
10. Synthetic hydrogel mimics of the nuclear pore complex for the study of nucleocytoplasmic transport defects in C9orf72 ALS/FTD.
Friedman AK; Boeynaems S; Baker LA
Anal Bioanal Chem; 2022 Jan; 414(1):525-532. PubMed ID: 34170347
[TBL] [Abstract][Full Text] [Related]
11. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
Starr A; Sattler R
Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
[TBL] [Abstract][Full Text] [Related]
12. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
Gascon E; Gao FB
J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
[TBL] [Abstract][Full Text] [Related]
13. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
Ji AL; Zhang X; Chen WW; Huang WJ
J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
[TBL] [Abstract][Full Text] [Related]
14. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
[TBL] [Abstract][Full Text] [Related]
15. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
16. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.
Lall D; Baloh RH
J Clin Invest; 2017 Sep; 127(9):3250-3258. PubMed ID: 28737506
[TBL] [Abstract][Full Text] [Related]
17. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
[TBL] [Abstract][Full Text] [Related]
18. Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD.
Khalil B; Linsenmeier M; Smith CL; Shorter J; Rossoll W
Mol Neurodegener; 2024 Jan; 19(1):8. PubMed ID: 38254150
[TBL] [Abstract][Full Text] [Related]
19. LINC complex alterations are a key feature of sporadic and familial ALS/FTD.
Sirtori R; J Gregoire M; M Potts E; Collins A; Donatelli L; Fallini C
Acta Neuropathol Commun; 2024 Apr; 12(1):69. PubMed ID: 38664831
[TBL] [Abstract][Full Text] [Related]
20. Unraveling the impact of disrupted nucleocytoplasmic transport systems in
McGoldrick P; Robertson J
Front Cell Neurosci; 2023; 17():1247297. PubMed ID: 37720544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
